Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial.
Alves Costa Silva C, Piccinno G, Suissa D, Bourgin M, Schreibelt G, Durand S, Birebent R, Fidelle M, Sow C, Aprahamian F, Manghi P, Punčochář M, Asnicar F, Pinto F, Armanini F, Terrisse S, Routy B, Drubay D, Eggermont AMM, Kroemer G, Segata N, Zitvogel L, Derosa L, Bol KF, de Vries IJM.
Alves Costa Silva C, et al. Among authors: suissa d.
Nat Commun. 2024 Feb 23;15(1):1633. doi: 10.1038/s41467-024-45357-1.
Nat Commun. 2024.
PMID: 38395948
Free PMC article.